Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines
Year: 2024
Type: article
Abstract: Citrus wastewater from industries is a source of bioactive compounds whose recovery could be a useful approach to convert processing waste into potential resources to be exploited in food, pharmaceutical, and chemical companies. Citrus wastewater, obtained from the industrial processing of Citrus sinensis, was freeze-dried and qualitative/quantitative evaluated using HPLC/MS Q-TOF analysis. Antiproliferative activity was investigated on MDA-MB-231 (triple-negative breast cancer cell line), MCF-7 (breast cancer cell line), and its multidrug-resistant variant MCF-7R. Fraction 8 emerged for its cytotoxicity toward MCF-7R cells. Its main component, the polymethoxylated flavone nobiletin (80%), is likely involved in increasing the number of G1-phase MCF-7R cells without inducing cell death. Notably, fraction 8 sensitizes MCF7-R cells to the antiproliferative effects of doxorubicin, thus contributing to overcoming MCF7-R multidrug resistance. Our studies highlighted the possibility of applying a sustainable strategy for citrus wastewater recycling to recover functional compounds as useful adjuvants for the prevention and treatment of malignancies.
Source: Archiv der Pharmazie
Authors: Maria Valeria Raimondi, Salvatrice Rigogliuso, Filippo Saiano, Paola Poma, Manuela Labbozzetta, Marilia Barreca, Marcella Barbera, Roberta Bivacqua, Giovanna Li Petri, Silvestre Buscemi, Ignazio Sardo, Virginia Spanò, Antonio Palumbo Piccionello, Alessandra Montalbano, Paola Barraja, Monica Notarbartolo
Language: English
Subfield: Plant Science
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,300
Awards: G3468787282, G6053338378
OpenAlex ID: W4403139697
